Microbubble

Kohler Co. Showcases Innovation in Design Leadership and Wellness at KBIS 2024

Retrieved on: 
Monday, February 26, 2024

Guests are encouraged to explore all the latest products throughout the impressive space with a focus on color and design leadership, sustainable living, and wellness.

Key Points: 
  • Guests are encouraged to explore all the latest products throughout the impressive space with a focus on color and design leadership, sustainable living, and wellness.
  • For more than 150 years, Kohler has built a legacy of design leadership through innovation and craftmanship.
  • Wellness brand Sprig by Kohler amplifies the bathing experience, offering clean aromatherapy that infuses the space with soothing botanicals.
  • To learn more about Kohler Co. brands and products, please visit the Kohler KBIS Press Kit.

Kohler Brings Design Leadership and Smart Home Wellness Experiences to CES 2024

Retrieved on: 
Friday, January 5, 2024

KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.

Key Points: 
  • KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.
  • Integration with the Kohler Konnect app provides remote access and control of personalized presets, giving users access to seamless customization from anywhere.
  • Formation 01 defies traditional faucet design and performance and was developed by Kohler in partnership with Dr. Samuel Ross and his industrial design studio SR_A.
  • To learn more about Kohler's CES booth experience and full product lineup, visit the KOHLER CES Press Kit .

Kohler Brings Design Leadership and Smart Home Wellness Experiences to CES 2024

Retrieved on: 
Friday, January 5, 2024

KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.

Key Points: 
  • KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.
  • Integration with the Kohler Konnect app provides remote access and control of personalized presets, giving users access to seamless customization from anywhere.
  • Formation 01 defies traditional faucet design and performance and was developed by Kohler in partnership with Dr. Samuel Ross and his industrial design studio SR_A.
  • To learn more about Kohler's CES booth experience and full product lineup, visit the KOHLER CES Press Kit .

Embrace Exquisite Living with Innovative Personal Care Products at the 134th Canton Fair

Retrieved on: 
Tuesday, October 31, 2023

Guangzhou Xujohn Bio-technique Co., Ltd. presented its Hydrogel Eye Mask at the Canton Fair, a cutting-edge product that embodies their commitment to sustainability.

Key Points: 
  • Guangzhou Xujohn Bio-technique Co., Ltd. presented its Hydrogel Eye Mask at the Canton Fair, a cutting-edge product that embodies their commitment to sustainability.
  • Shanghai Shift Electrics Co., Ltd. brought an array of oral care products to the Canton Fair, where one of their highlights is the smart handheld dental rinser.
  • Personal Care Products showcases a diverse range of innovative products, extending a genuine welcome to buyers worldwide to uncover potential business openings and embrace exquisite living.
  • To gather additional details about the 134th Canton Fair, please visit the official website of the Canton Fair at https://www.cantonfair.org.cn/en-US/posts/646531331412942848 , or contact [email protected] .

Cordance Medical's NeuroAccess Receives FDA Breakthrough Device Designation for Liquid Biopsy in Brain Tumors

Retrieved on: 
Thursday, October 26, 2023

MOUNTAIN VIEW, Calif., Oct. 26, 2023 /PRNewswire/ -- Cordance Medical, a pioneering medical device company focused on opening the Blood-Brain Barrier (BBB) to facilitate liquid biopsy, announces that its NeuroAccess™ device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • MOUNTAIN VIEW, Calif., Oct. 26, 2023 /PRNewswire/ -- Cordance Medical, a pioneering medical device company focused on opening the Blood-Brain Barrier (BBB) to facilitate liquid biopsy, announces that its NeuroAccess™ device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
  • The FDA's Breakthrough Device Designation is conferred upon technologies that offer superior treatment or diagnosis for life-threatening or debilitating conditions.
  • "This Breakthrough Device Designation from the FDA is a pivotal milestone for Cordance Medical and for patients requiring more efficacious diagnostic solutions," said Ryan Dittamore, CEO of Cordance Medical.
  • "The Breakthrough Device Designation demonstrates Cordance Medical's commitment to design a safe, patient-centric device for patients with brain diseases," added Dr. Ramamurthy, CTO and co-founder of Cordance Medical.

Global Contrast-Enhanced Ultrasound Market Set to Reach $2.1 Billion by 2028, Driven by Rising Geriatric Population and Research Activities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 26, 2023

The global contrast-enhanced ultrasound market is projected to experience substantial growth, reaching USD 2.1 billion by 2028, up from USD 1.6 billion in 2023, with a CAGR of 6.1% from 2023 to 2028.

Key Points: 
  • The global contrast-enhanced ultrasound market is projected to experience substantial growth, reaching USD 2.1 billion by 2028, up from USD 1.6 billion in 2023, with a CAGR of 6.1% from 2023 to 2028.
  • Key factors driving this growth include the rising geriatric population and increased usage of contrast agents.
  • Additionally, growing research and development activities, government initiatives, and a rising number of clinical trials are contributing to the expansion of the contrast-enhanced ultrasound market.
  • The Asia Pacific region is expected to witness the highest growth in the contrast-enhanced ultrasound market during the forecast period.

Simple Contrast Ultrasound Scan Resolves Indeterminate MR and CT

Retrieved on: 
Friday, September 8, 2023

A simple, noninvasive contrast enhanced ultrasound (CEUS) scan is an ideal tool for resolving frequent indeterminate MR and CT scans, according to Dr. Stephanie Wilson, a clinical professor of radiology and gastroenterology at the University of Calgary and Co-President of the International Contrast Ultrasound Society.

Key Points: 
  • A simple, noninvasive contrast enhanced ultrasound (CEUS) scan is an ideal tool for resolving frequent indeterminate MR and CT scans, according to Dr. Stephanie Wilson, a clinical professor of radiology and gastroenterology at the University of Calgary and Co-President of the International Contrast Ultrasound Society.
  • “CEUS often overcomes limitations of MR and CT in diagnosing many tumors and detecting their recurrence,” said Dr. Wilson, who spoke today at the International Bubble Conference in Chicago.
  • In addition, “CEUS scans are significantly less expensive than MR and CT,” she said.
  • Ultrasound contrast agents are currently available worldwide from Bracco, Lantheus and GE Healthcare.

Akadeum Life Sciences Release their Revolutionary Human T cell Activation and Expansion Kit

Retrieved on: 
Tuesday, August 29, 2023

ANN ARBOR, Mich., Aug. 29, 2023 /PRNewswire/ -- Akadeum Life Sciences , the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell Activation & Expansion Kit' with Buoyancy Activated Cell Sorting (BACS) microbubbles.

Key Points: 
  • ANN ARBOR, Mich., Aug. 29, 2023 /PRNewswire/ -- Akadeum Life Sciences , the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell Activation & Expansion Kit' with Buoyancy Activated Cell Sorting (BACS) microbubbles.
  • Current cell isolation methods include magnetic activated cell separation (MACS®) and fluorescence-activated cell sorting (FACS).
  • Akadeum's 'Human T Cell Activation & Expansion Kit' is an addition to our expanding portfolio of products.
  • Our kit rapidly simplifies, optimizes, and streamlines the cell therapy workflow for professionals, ultimately making cell and gene therapy available for all of those in need."

Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines at ASGCT 26th Annual Meeting

Retrieved on: 
Tuesday, May 16, 2023

ANN ARBOR, Mich., May 16, 2023 /PRNewswire/ -- Akadeum Life Sciences, a global leader in buoyancy-based cell separation and activation technology, is announcing the launch of a new series of products for cell therapy research and development—enabling direct leukopak human immune cell isolation and T-cell activation/expansion kits at the American Society of Gene + Cell Therapy's 26th Annual Meeting from May 16-20, 2023 in Los Angeles, California. The new products expand Akadeum's lineup of Buoyancy-Activated Cell Sorting (BACS™) Microbubble buoyancy-based cell isolation kits, enabling the direct isolation of T cells (leveraging GMP-grade kit reagents) and peripheral blood mononuclear cells (PBMCs) from leukapheresis material without the need for lysis or density gradient centrifugation.

Key Points: 
  • The company that pioneered microbubbles for cell isolation is launching a first-of-its-kind product that uses microbubbles to activate T Cells and releasing the first GMP-grade microbubble product for T cell isolation.
  • This innovative advancement will give immunotherapy researchers the ability to produce high-yield, purified PBMCs and T cells in just one hour while remaining gentle on fragile immune cells.
  • Akadeum's product launch includes three new kits:
    All three kits use Akadeum's signature BACS™ Microbubble technology to drive powerful large-scale cell isolation, activation, and expansion—all while being gentle on cells.
  • The Human T Cell Activation & Expansion Kit does not compromise T cell expansion kinetics or activation strength while producing T cell populations with significantly less expression of exhaustion markers compared to competitors' products.

Global Contrast Media Strategic Business Report 2023: Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI

Retrieved on: 
Wednesday, March 29, 2023

DUBLIN, March 29, 2023 /PRNewswire/ -- The "Contrast Media: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 29, 2023 /PRNewswire/ -- The "Contrast Media: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • Taking into account the ongoing post pandemic recovery, growth in the Magnetic Resonance Imaging (mri) segment is readjusted to a revised 3.7% CAGR for the next 8-year period.
  • The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel.
  • Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand.